Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.

Légaré S, Basik M.

Mol Endocrinol. 2016 Sep;30(9):965-76. doi: 10.1210/me.2016-1072. Epub 2016 Jul 20. Review.

2.

LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP.

Bennesch MA, Segala G, Wider D, Picard D.

Nucleic Acids Res. 2016 Oct 14;44(18):8655-8670. Epub 2016 Jun 20.

3.

Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells.

Cao X, Liu B, Cao W, Zhang W, Zhang F, Zhao H, Meng R, Zhang L, Niu R, Hao X, Zhang B.

Chin J Cancer Res. 2013 Apr;25(2):212-22. doi: 10.3978/j.issn.1000-9604.2013.04.01.

4.

Autophagy modulation as a target for anticancer drug discovery.

Li X, Xu HL, Liu YX, An N, Zhao S, Bao JK.

Acta Pharmacol Sin. 2013 May;34(5):612-24. doi: 10.1038/aps.2013.23. Epub 2013 Apr 8. Review.

5.

Histone deacetylases as targets for treatment of multiple diseases.

Tang J, Yan H, Zhuang S.

Clin Sci (Lond). 2013 Jun;124(11):651-62. doi: 10.1042/CS20120504. Review.

6.

Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells.

Lee YJ, Won AJ, Lee J, Jung JH, Yoon S, Lee BM, Kim HS.

Int J Med Sci. 2012;9(10):881-93. doi: 10.7150/ijms.5011. Epub 2012 Nov 7.

7.

Ume6 transcription factor is part of a signaling cascade that regulates autophagy.

Bartholomew CR, Suzuki T, Du Z, Backues SK, Jin M, Lynch-Day MA, Umekawa M, Kamath A, Zhao M, Xie Z, Inoki K, Klionsky DJ.

Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11206-10. doi: 10.1073/pnas.1200313109. Epub 2012 Jun 25.

8.

Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis.

Rattan R, Ali Fehmi R, Munkarah A.

J Oncol. 2012;2012:928127. doi: 10.1155/2012/928127. Epub 2012 Jun 4.

Supplemental Content

Support Center